KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Financing Activities (2016 - 2025)

Encompass Health (EHC) has disclosed Cash from Financing Activities for 17 consecutive years, with -$97.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 35.45% year-over-year to -$97.4 million, compared with a TTM value of -$431.2 million through Dec 2025, down 30.43%, and an annual FY2025 reading of -$431.2 million, down 30.43% over the prior year.
  • Cash from Financing Activities was -$97.4 million for Q4 2025 at Encompass Health, up from -$113.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $42.3 million in Q4 2021 and bottomed at -$186.4 million in Q2 2021.
  • Average Cash from Financing Activities over 5 years is -$67.2 million, with a median of -$59.4 million recorded in 2022.
  • The sharpest move saw Cash from Financing Activities skyrocketed 111.94% in 2021, then tumbled 404.68% in 2024.
  • Year by year, Cash from Financing Activities stood at $42.3 million in 2021, then plummeted by 139.01% to -$16.5 million in 2022, then tumbled by 81.21% to -$29.9 million in 2023, then crashed by 404.68% to -$150.9 million in 2024, then soared by 35.45% to -$97.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for EHC at -$97.4 million in Q4 2025, -$113.2 million in Q3 2025, and -$90.2 million in Q2 2025.